Note: Ingredients listed on restricted chemical lists
EC/CAS
9016-87-9
Name of the chemical
4,4'-Methylendiphenyldiisocyanat tech. (Polymeres) MDI, pMDI (in Form atembarer Aerosole, A-Fraktion)
Concentration
≥25 - ≤50
EC/CAS
202-966-0/101-68-8
Name of the chemical
4,4’-Methylenediphenyl diisocyanate
Concentration
≥25-≤49
EC/CAS
227-534-9/5873-54-1
Name of the chemical
2,4’-Methylenediphenyl diisocyanate
Concentration
≥1.0-≤5.0
EC/CAS
247-714-0/26447-40-5
Name of the chemical
Methylenediphenyl diisocyanate (see also specific isomers)
Concentration
≥1.0-≤5.0
EC/CAS
219-799-4/2536-05-2
Name of the chemical
2,2’-Methylenediphenyl diisocyanate
Concentration
<1.0
General Information
Version
10.05
Revision date
2019-09-23
Product name
910-175 CURING SOLUTION
1.2.1 Relevant identified uses
Industrial applications
Emergency telephone
+33 (0)3 27 19 35 00
Icons in SDS
Company Information
company name
PPG Coatings S.A
e-mail address of the competent person responsible for the Safety Data Sheet
AeroPSreachEMEA@ppg.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H225, H315, H317, H319, H332, H334, H335, H351, H373
Hazard statements
Code
Statements
H225
Highly Flammable liquid and vapour
Section 2
SECTION 2: Hazards identification
1272/2008] Classification of the substance or mixture
Product definition
Mixture
Signal word
Danger
Hazard statements
Highly flammable liquid and vapour. Harmful if inhaled. Causes serious eye irritation. Causes skin irritation. May cause allergy or asthma symptoms or breathing difficulties if inhaled. May cause an allergic skin reaction. Suspected of causing cancer. May cause respiratory irritation. May cause damage to organs through prolonged or repeated exposure.
Prevention
Wear protective gloves. Wear protective clothing. Wear eye or face protection. Wear respiratory protection. Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. Do not breathe vapour.
Response
IF INHALED: Remove person to fresh air and keep comfortable for breathing. If experiencing respiratory symptoms: Call a POISON CENTER or physician. IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
Storage
Store in a well-ventilated place. Keep cool.
Disposal
Not applicable. P280, P284, P210, P260, P304 + P340, P342 + P311, P303 + P361 + P353, P305 + P351 + P338, P403, P235
Hazardous Ingredients
Isocyanic acid, polymethylenepolyphenylene ester 4,4’-methylenediphenyl diisocyanate o-(p-isocyanatobenzyl)phenyl isocyanate methylenediphenyl diisocyanate 2,4-dioxo-1,3-diazetidine-1,3-diylbis[p-phenylenemethylene-p-phenylene] diisocyanate 2,2’-methylenediphenyl diisocyanate Isocyanic acid, polymethylenepolyphenylene ester, polymer with .alpha.-hydro-. omega.-hydroxypoly(oxy-1,2-ethanediyl)
Supplemental label elements
Contains isocyanates. May produce an allergic reaction. elements
Annex XVII - Restrictions on the manufacture, placing on the market and use of certain dangerous substances, mixtures and articles
Not applicable.
Special packaging requirements
Containers to be fitted Not applicable. with child-resistant fastenings
Tactile warning of danger
Not applicable.
2.3 Other hazards
Product meets the criteria This mixture does not contain any substances that are assessed to be a PBT or a for PBT or vPvB vPvB.
Other hazards which do not result in classification
Prolonged or repeated contact may dry skin and cause irritation.
2.1 Classification of the substance or mixture
Product definition : Mixture Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS] SECTION 2: Hazards identification Flam. Liq. 2, H225 Acute Tox. 4, H332 Skin Irrit. 2, H315 Eye Irrit. 2, H319 Resp. Sens. 1, H334 Skin Sens. 1, H317 Carc. 2, H351 STOT SE 3, H335 STOT RE 2, H373 The product is classified as hazardous according to Regulation (EC) 1272/2008 as amended. See Section 16 for the full text of the H statements declared above. See Section 11 for more detailed information on health effects and symptoms.